S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
NASDAQ:INMD

InMode - INMD Stock Forecast, Price & News

$35.24
-1.19 (-3.27%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$35.16
▼
$36.94
50-Day Range
$30.23
▼
$38.71
52-Week Range
$20.60
▼
$73.75
Volume
798,146 shs
Average Volume
1.82 million shs
Market Capitalization
$2.93 billion
P/E Ratio
17.02
Dividend Yield
N/A
Price Target
$46.60

InMode MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
32.2% Upside
$46.60 Price Target
Short Interest
Bearish
7.78% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
20.10%
From $2.09 to $2.51 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.35 out of 5 stars

Medical Sector

164th out of 1,022 stocks

Electromedical Equipment Industry

7th out of 23 stocks

See Top Rated MarketRank™ Stocks Here
INMD stock logo

About InMode (NASDAQ:INMD) Stock

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Receive INMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter.

INMD Stock News Headlines

November 23, 2022 | finance.yahoo.com
Is InMode Stock a Buy Now?
November 16, 2022 | finance.yahoo.com
Up 58% in 6 Months, Is InMode Stock Still a Bargain Buy?
December 9, 2022 | Investing Trends (Ad)
"We need batteries. Literally everywhere."
Pretty much every technological megatrend today requires batteries. That includes EVs... 5G... AI... charging stations... and smart energy storage systems. Find out why the U.S. just added graphite to a list of super-critical minerals, calling it "essential for America's National Defense."
November 10, 2022 | finance.yahoo.com
Get Into This Growth Stock for 2023 and Beyond
November 1, 2022 | finance.yahoo.com
InMode to Present at Upcoming Investor Conferences Before the End of 2022
October 30, 2022 | finance.yahoo.com
Why InMode Stock Ignited This Week
October 27, 2022 | finance.yahoo.com
InMode Ltd. (INMD) Q3 2022 Earnings Call Transcript
October 27, 2022 | finance.yahoo.com
InMode Reports Third Quarter 2022 Financial Results; Record Quarterly Revenue of $121.2 M, Represents 29% Year-Over-Year Growth
December 9, 2022 | Investing Trends (Ad)
"We need batteries. Literally everywhere."
Pretty much every technological megatrend today requires batteries. That includes EVs... 5G... AI... charging stations... and smart energy storage systems. Find out why the U.S. just added graphite to a list of super-critical minerals, calling it "essential for America's National Defense."
October 19, 2022 | investorplace.com
7 Quality Stocks Selling at a Discount as Q4 Kicks Off - InvestorPlace
October 17, 2022 | seekingalpha.com
InMode Stock: Lack Of Growth Catalysts Could Hamper Its Recovery - Seeking Alpha
October 14, 2022 | nasdaq.com
InMode (NASDAQ:INMD) Knows How To Allocate Capital Effectively - Nasdaq
October 13, 2022 | finance.yahoo.com
Meta's top product design executive announces departure - Yahoo Finance
October 13, 2022 | finance.yahoo.com
Leonardo Dicaprio-backed fintech Aspiration names new Chief Executive Officer - Yahoo Finance
October 13, 2022 | finance.yahoo.com
Germany's Lindner: Ukraine's 2022 financial needs are covered - Yahoo Finance
October 13, 2022 | finance.yahoo.com
US STOCKS SNAPSHOT-Futures jump after report on UK budget - Yahoo Finance
October 13, 2022 | finance.yahoo.com
U.S. Treasury's Yellen says CPI data shows more work needed to control inflation - Yahoo Finance
October 13, 2022 | finance.yahoo.com
U.S. reviewing consequences for relations with Saudi Arabia over OPEC+ decision - Yahoo Finance
October 13, 2022 | finance.yahoo.com
Russian c.bank says rouble strengthening effect on prices is waning - Yahoo Finance
October 13, 2022 | finance.yahoo.com
Facebook parent seeks dismissal of U.S. challenge to Within Unlimited deal - Yahoo Finance
October 13, 2022 | benzinga.com
InMode shares are trading higher after the company issued Q3 sales guidance above estimates and raised FY22 sales guidance above estimates. - InMode (NASDAQ:INMD) - Benzinga
October 13, 2022 | finance.yahoo.com
Here's Why InMode Stock Soared Today
October 13, 2022 | finance.yahoo.com
InMode Expects Record Third Quarter 2022 Revenue of $120.5M-$120.9M, Raising Full-Year 2022 Revenue Guidance to $445M-450M
October 10, 2022 | finance.yahoo.com
InMode's (NASDAQ:INMD) three-year earnings growth trails the 37% YoY shareholder returns - Yahoo Finance
October 10, 2022 | finance.yahoo.com
InMode's (NASDAQ:INMD) three-year earnings growth trails the 37% YoY shareholder returns
October 7, 2022 | finance.yahoo.com
Notice of 2022 Third Quarter Results Conference Call and Webcast for Investors and Analysts - Yahoo Finance
October 5, 2022 | seekingalpha.com
InMode Stock: Recession May Kill Consumer Demand (NASDAQ:INMD) - Seeking Alpha
See More Headlines
Receive INMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter.

INMD Company Calendar

Last Earnings
10/26/2021
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/09/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:INMD
CUSIP
N/A
CIK
885988
Web
www.inmodemd.com
Phone
972-4909-7470
Fax
N/A
Employees
362
Year Founded
2008

Price Target and Rating

Average Stock Price Forecast
$46.60
High Stock Price Forecast
$60.00
Low Stock Price Forecast
$40.00
Forecasted Upside/Downside
+32.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$2.07
Trailing P/E Ratio
17.02
Forward P/E Ratio
16.86
P/E Growth
N/A
Net Income
$164.97 million
Net Margins
40.93%
Pretax Margin
44.49%
Return on Equity
39.52%
Return on Assets
34.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.74
Quick Ratio
9.12

Sales & Book Value

Annual Sales
$357.57 million
Price / Sales
8.20
Cash Flow
$1.96 per share
Price / Cash Flow
17.94
Book Value
$5.00 per share
Price / Book
7.05

Miscellaneous

Outstanding Shares
83,241,000
Free Float
77,481,000
Market Cap
$2.93 billion
Optionable
Not Optionable
Beta
2.20

Social Links


Key Executives

  • Mr. Yair Malca (Age 44)
    Chief Financial Officer
    Comp: $525k
  • Mr. Alon Yaari
    VP of Operations
  • Ms. Nava Tal-Launer
    Chief Information Officer
  • Mr. Shakil Lakhani (Age 39)
    Pres of North America
    Comp: $2.67M
  • Dr. Spero Theodorou M.D. (Age 50)
    Chief Medical Officer
    Comp: $1.84M
  • Mr. Moshe Mizrahy (Age 69)
    Chairman & CEO
  • Dr. Michael Kreindel (Age 54)
    CTO & Director

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













INMD Stock - Frequently Asked Questions

Should I buy or sell InMode stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for InMode in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" INMD shares.
View INMD analyst ratings or view top-rated stocks.

What is InMode's stock price forecast for 2023?

4 brokers have issued twelve-month price targets for InMode's shares. Their INMD share price forecasts range from $40.00 to $60.00. On average, they anticipate the company's share price to reach $46.60 in the next year. This suggests a possible upside of 30.7% from the stock's current price.
View analysts price targets for INMD or view top-rated stocks among Wall Street analysts.

How have INMD shares performed in 2022?

InMode's stock was trading at $70.58 at the beginning of 2022. Since then, INMD stock has decreased by 49.5% and is now trading at $35.66.
View the best growth stocks for 2022 here.

When is InMode's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 9th 2023.
View our INMD earnings forecast.

How were InMode's earnings last quarter?

InMode Ltd. (NASDAQ:INMD) posted its quarterly earnings data on Tuesday, October, 26th. The healthcare company reported $0.55 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.50 by $0.05. The healthcare company had revenue of $94.18 million for the quarter, compared to analysts' expectations of $89.38 million. InMode had a net margin of 40.93% and a trailing twelve-month return on equity of 39.52%. The business's revenue for the quarter was up 57.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.31 earnings per share.

When did InMode's stock split?

InMode's stock split on Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly issued shares were distributed to shareholders after the closing bell on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What guidance has InMode issued on next quarter's earnings?

InMode updated its FY 2022 earnings guidance on Thursday, November, 3rd. The company provided earnings per share guidance of $2.28-$2.30 for the period, compared to the consensus earnings per share estimate of $2.22. The company issued revenue guidance of $445.00 million-$450.00 million, compared to the consensus revenue estimate of $440.81 million.

What is Moshe Mizrahy's approval rating as InMode's CEO?

1 employees have rated InMode Chief Executive Officer Moshe Mizrahy on Glassdoor.com. Moshe Mizrahy has an approval rating of 100% among the company's employees. This puts Moshe Mizrahy in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of InMode own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InMode investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Micron Technology (MU), AbbVie (ABBV), Advanced Micro Devices (AMD), Block (SQ), Tesla (TSLA), DocuSign (DOCU) and PayPal (PYPL).

When did InMode IPO?

(INMD) raised $75 million in an IPO on Thursday, August 8th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. ​Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager.

What is InMode's stock symbol?

InMode trades on the NASDAQ under the ticker symbol "INMD."

Who are InMode's major shareholders?

InMode's stock is owned by a variety of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (2.76%), BlackRock Inc. (2.25%), Meitav Dash Investments Ltd. (1.96%), Two Sigma Advisers LP (1.28%), Point72 Asset Management L.P. (1.23%) and Migdal Insurance & Financial Holdings Ltd. (1.01%).

How do I buy shares of InMode?

Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InMode's stock price today?

One share of INMD stock can currently be purchased for approximately $35.66.

How much money does InMode make?

InMode (NASDAQ:INMD) has a market capitalization of $2.97 billion and generates $357.57 million in revenue each year. The healthcare company earns $164.97 million in net income (profit) each year or $2.07 on an earnings per share basis.

How many employees does InMode have?

The company employs 362 workers across the globe.

Does InMode have any subsidiaries?
The following companies are subsidiares of InMode: Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd..
Read More
How can I contact InMode?

InMode's mailing address is TAVOR BUILDING SHAAR YOKNEAM POB 533, YOKNEAM L3, 2069200. The official website for the company is www.inmodemd.com. The healthcare company can be reached via phone at 972-4909-7470 or via email at ir@inmodemd.com.

This page (NASDAQ:INMD) was last updated on 12/9/2022 by MarketBeat.com Staff